Max-Planck-Institut für Experimentelle Medizin | |
.jpg) | |
| Abbreviation | MPIEM |
|---|---|
| Predecessor | Kaiser Wilhelm Institute for Medical Research |
| Successor | Max Planck Institute for Multidisciplinary Sciences |
| Formation | 1947 |
| Type | Scientific institute |
| Legal status | Underwent merger with the Max Planck Institute for Biophysical Chemistry |
| Purpose | Research on experimental medicine in neuroscience |
| Headquarters | Göttingen, Lower Saxony, Germany |
Parent organization | Max Planck Society |
Formerly called | Medical Research Institution of the Kaiser Wilhelm Society |
The Max Planck Institute of Experimental Medicine (German: Max-Planck-Institut für Experimentelle Medizin) was a research institute of the Max Planck Society, located in Göttingen, Germany. On January 1, 2022, the institute merged with the Max Planck Institute for Biophysical Chemistry in Göttingen to form the Max Planck Institute for Multidisciplinary Sciences.[1]
It was founded in 1947 as the Medical Research Institution of the Kaiser Wilhelm Society (German: Medizinische Forschungsanstalt der Kaiser-Wilhelm-Gesellschaft), and was integrated into the Max Planck Society in 1948. It retained its original name until 1965. The research focus of the institute was on neuroscience: its research activities were organized into the Department of Neurogenetics, the Department of Molecular Neurobiology, and the Department of Molecular Biology of Neuron Signals.
- ^ "New Max Planck Institute in Göttingen Combines Natural and Medical Sciences" (Press release). Max Planck Institute for Multidisciplinary Sciences. January 3, 2022. Retrieved February 5, 2022.